Massachusetts court upholds $63M judgment against J&J
Apr. 17, 2015
BOSTON (AP) — The highest court in Massachusetts has upheld a $63 million judgment against the manufacturer of Children's Motrin awarded to a family whose daughter developed a life-threatening disease after taking the over-the-counter medicine.
A jury ruled in 2013 that the McNeil Consumer Healthcare unit of Johnson & Johnson failed to provide sufficient warnings about potential side effects.
Samantha Reckis was 7 in 2003 when she was given the ibuprofen product for a fever. She developed a rare skin disease known as toxic epidermal necrolysis and was blinded.
The company appealed, saying the family failed to prove the medicine caused the disease and damages were excessive.
The Supreme Judicial Court rejected those arguments on Friday.
The company said it's reviewing the decision, adding that while it sympathizes with the family, Motrin has been used safely millions of times.